Maximo F. Nougues - 02 Aug 2022 Form 4 Insider Report for PUMA BIOTECHNOLOGY, INC. (PBYI)

Role
Chief Financial Officer
Signature
/s/ Gordon Esplin as attorney-in-fact for Maximo F. Nougues
Issuer symbol
PBYI
Transactions as of
02 Aug 2022
Transactions value $
-$465
Form type
4
Date filed
04 Aug 2022, 21:34
Previous filing
04 Aug 2022
Next filing
07 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBYI Common Stock Sale -$465 -161 -0.14% $2.89 112K 02 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program.